# GLASSIA

NDC: 0944-2884
Generic name: ALPHA.1-PROTEINASE INHIBITOR HUMAN
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20100701

FDA application: BLA125325

## Active ingredients

- .ALPHA.1-PROTEINASE INHIBITOR HUMAN: 1 g/50mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0944-2884"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0944-2884